No-Implant Shunt Eases HF Symptoms in Early Data Quality of life consistently improved across first-in-man studies May 20, 2022
Device Type Matters for Valve-in-Valve TAVR in Small Anatomies Showdown between Sapien and Evolut valves in the LYTEN trial May 20, 2022
Harmony Pulmonary Valves 'Behaving' at 1 Year Pooled study data show no mortality, favorable clinical outcomes May 20, 2022
TAVR Stays Its Course as 10-Year Durability Data Trickle In Glimpse of longer-term valve degeneration in early TAVR patients May 19, 2022
Do Pediatric Electrophysiologists Have It Harder? Clinicians discuss the dilemmas and shortcomings in the field May 02, 2022
Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM First-in-class mavacamten will be subject to REMS, however Apr 29, 2022
In These Patients, NT-proBNP Underestimates Heart Failure Risk Is it time for sex- and race-specific risk thresholds? Apr 27, 2022
Even With CKD, Patiromer Helped Heart Failure Patients Keep Hyperkalemia at Bay Promising findings from prespecified renal analysis of the DIAMOND trial Apr 09, 2022
Systemic Corticosteroids in Acute HF: Worth Another Look? Some see a potential treatment for patients with more inflammation Apr 08, 2022
Stroke While on LVAD No Barrier to Successful Heart Transplant It doesn't help, for sure, but it doesn't seem to hurt greatly either Apr 05, 2022
TAVR Valve Outlasts Surgical Bioprostheses at 5 Years No longer assume that TAVR bioprostheses are inherently less durable Apr 05, 2022
Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors Apr 04, 2022
Transcatheter Tricuspid Repair Shows Early Promise PASCAL device safe and linked to symptom improvement in severe tricuspid regurgitation Apr 04, 2022
Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients But study in lower income countries sees hint of benefit during peak disease season Apr 04, 2022
EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable Apr 03, 2022
Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCM VALOR-HCM trial shows novel cardiac myosin inhibitor beneficial as targeted treatment Apr 02, 2022
Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
In-Person ACC Meeting Returns, Serving Diet Intervention Studies and More Will salt restriction finally get a boost at this weekend's meeting? Mar 31, 2022
Obstructive HCM: Will Septal Reduction Zapping Hold Up? More progress on PIMSRA at one Chinese center Mar 30, 2022
Cranberry's Vascular Effects; Cardioprotective Penile Vibrations; EHR Score for CAD Recent developments of interest in cardiovascular medicine Mar 22, 2022
In HFpEF, Do MRA Users Get as Much Benefit From an SGLT2 Inhibitor? EMPEROR-Preserved trial weighs in Mar 21, 2022
Ross Procedure Best for Fixing Aortic Valve in Younger Patients? Propensity-matched analysis may suggest it's time for "Ross Centers of Excellence" Mar 07, 2022
ARB-Cancer Link May Come Down to Cumulative Exposure Does a new paper resolve the conflicting safety data on the popular antihypertensives? Mar 02, 2022
AirPods-Pacemaker Risk; Not Enough Valve Interventions; Baby-Shaking Cardiologist Recent developments of interest in cardiovascular medicine Mar 01, 2022
Salt in Fizzy Tablets Linked to Heart, Death Risk Warning signals seen for fast-acting acetaminophen and other drugs Feb 24, 2022
A Simple Way to Tell When Asymptomatic Aortic Stenosis Isn't So Benign Could regular NT-proBNP testing be of value to patients with non-severe AS? Feb 16, 2022
ACIP Embraces Spikevax Amid Serious Talk of Changing mRNA Dosing Interval Would longer time between doses do the trick to reduce myocarditis risk? Feb 04, 2022
Gestational Diabetes Tied to Long-Term Cardiovascular Risks Chronic comorbidities partly explain risk, researcher says Feb 04, 2022
Adult Congenital Heart Surgery: Go for the Pediatric Specialists? Study suggests worse outcomes at adult centers with expertise in other heart surgeries Jan 31, 2022
Donor Hearts Can Withstand Longer Ischemic Times Over 4 hours not inherently more dangerous, one group finds Jan 31, 2022
Was DOAC to Blame for Patient's LVAD Pump Thrombosis? Direct oral anticoagulant tried after warfarin resistance fell short in this patient with obesity Jan 21, 2022
Signs of Lingering Cardiac Dysfunction After Severe COVID Study included people hospitalized before vaccines were available Jan 20, 2022
Caution: Paxlovid Interacts With Many Heart Meds The Skeptical Cardiologist asks clinicians and patients to take note Jan 17, 2022
Death During Sex: Not Just an Old Man Thing But sudden cardiac death remains rare even for sexually active people with heart conditions Jan 12, 2022
Sapien 3 With Pre-Stent Gets FDA Go-Ahead for Pulmonary Valve Fix Valve system could substantially expand proportion of patients who can skip another surgery Dec 20, 2021
ECG Monitoring for Post-TAVR Delayed Conduction Disturbances Put to the Test How long should monitoring last, and in whom? Dec 20, 2021
AHA Abstract Under Fire; Cardiology Bullies; An Acupuncture Needle Where?! Recent developments of interest in cardiovascular medicine Dec 07, 2021
The Right Ventricle Still Matters in LVAD Patients Right heart failure signaled trouble ahead in the Intermacs registry Nov 29, 2021
Hospitalized Acute HF Patients See Clinical Benefits With Empagliflozin EMPULSE results support early start for the SGLT2 inhibitor, but more data needed, expert says Nov 16, 2021
